Major trial to determine if ketamine can stop deadly epilepsy seizures (IMAGE)
Caption
“We wish to determine whether adding ketamine to existing treatment would terminate status epilepticus in more patients than the current treatment,” said neurologist Jaideep Kapur, MD, PhD, co-director of the University of Virginia’s Brain Institute and an epileptologist (epilepsy expert) at UVA Health and the UVA School of Medicine. “Our hope is that this trial can improve treatment guidelines for patients suffering from these dangerous seizures.”
Credit
UVA Health
Usage Restrictions
May be used to accompany news coverage of the ketamine trial. All other uses require express written permission from UVA Health.
License
Original content